Search Results 51-60 of 23991 for B cell lymphomas

  1. Non Hodgkin Clinical Trials - Mayo Clinic Research

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...

  2. Overview - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    These conditions include such cancers as multiple myeloma, Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), and such precursor conditions as monoclonal ...

  3. Publications - Thomas M. Habermann, M.D. - Mayo Clinic

    Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by Cell-of-Origin. ... B-cell lymphomas. Blood Cancer J. 2024 Oct ...

  4. Non-Hodgkin lymphoma - Survival rates - Mayo Clinic

    For stage 4 diffuse large B-cell lymphoma, the chance of surviving at least five years is about 55%. Follicular lymphoma is another common type of non-Hodgkin ...

  5. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell ...

  6. Study of Brentuximab Vedotin Combined With RCHOP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    Study of Brentuximab Vedotin Combined With RCHOP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) · Overview · Participation ...

  7. Marginal zone lymphoma - Diagnosis and treatment - Mayo Clinic

    Lymphoma cells collected from an endoscopy, lymph node biopsy, or bone ... B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn ...

  8. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...

  9. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy - Mayo Clinic

    Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy · Overview · Participation ...

  10. Mantle cell lymphoma - Diagnosis and treatment - Mayo Clinic

    There the CAR-T cells find and destroy the mantle cell lymphoma cells. ... B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn ...